While CREST-2 can stand as a guideline for understanding ACS therapies in case-by-case scenarios, it’s critical that trial conclusions do not replace clinical judgment and years of previous research.
The post Why CREST-2 Trial Results Should Inform, Not Replace, Clinical Judgment appeared first on MedCity News.
